Holen Sie sich die Stockscreener-App
10.64
1.33%
0.14
Handel nachbörslich:
10.64
Schlusskurs vom Vortag:
$10.50
Offen:
$10.55
24-Stunden-Volumen:
39,083
Relative Volume:
2.08
Marktkapitalisierung:
$234.72M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+3.70%
1M Leistung:
+4.21%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$10.35
$10.69
1-Wochen-Bereich:
$10.33
$10.69
52-Wochen-Spanne:
$10.11
$10.69
Helix Acquisition Corp Iii Stock (HLXC) Company Profile
Firmenname
Helix Acquisition Corp Iii
Sektor
Branche
Telefon
(857) 702-0370
Adresse
C/O CORMORANT ASSET MANAGEMENT LP, BOSTON
Compare HLXC vs LION, XXI, UMAC, CCXI, DMII
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HLXC
Helix Acquisition Corp Iii
|
10.64 | 231.63M | 0 | 0 | 0 | 0.00 |
LION
Lionsgate Studios Corp
|
15.31 | 4.77B | 2.63B | -175.60M | 11.40M | -0.7173 |
XXI
Twenty One Capital Inc
|
4.95 | 1.85B | 0 | 4.35M | 456.40K | 0.3397 |
UMAC
Unusual Machines Inc
|
22.30 | 912.86M | 17.25M | -5.64M | -40.16M | -0.3337 |
CCXI
Churchill Capital Corp Xi
|
17.45 | 772.00M | 0 | 0 | 0 | 0.0647 |
DMII
Drugs Made In America Acquisition Ii Corp
|
10.06 | 640.19M | 0 | 8.58M | -1.11M | 0.134 |
Helix Acquisition Corp Iii Aktie (HLXC) Neueste Nachrichten
Helix Acquisition Corp II (HLXB) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
MoonLake Immunotherapeutics (NASDAQ: MLTX) offers 9M shares at $20; 1M pre-funded warrants - Stock Titan
MoonLake Immunotherapeutics (NASDAQ: MLTX) seeks $150M via offering - Stock Titan
SpaceX and SanDisk among market cap stock movers on Monday By Investing.com - Investing.com South Africa
SpaceX and SanDisk among market cap stock movers on Monday - Investing.com UK
Helix Acquisition Corp II (HLXB) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Helix Acquisition Corp II (HLXB) Valuation: PE, PB & Fair Value Analysis - TradingKey
Helix Acquisition Corp II (HLXB) Institutional Confidence - TradingKey
Helix Acquisition Corp II (HLXB) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Helix Acquisition Corp II (HLXB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Helix Acquisition Corp II (HLXB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Helix Acquisition Corp II (HLXB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Helix Acquisition Corp II (HLXB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
GRO Relocates to Doha After Securing Qatari GrowthX Capital InvestmentReturn On Equity - newsline.com
Berkshire Hathaway Viewed as AI-Resilient by Greenskeeper Asset ManagementSubscription Growth Report - newsline.com
SpaceX Joins Nasdaq After Record-Breaking Public OfferingEPS Growth Report - newsline.com
JNJ Q1 2026 Earnings: Adjusted EPS Slightly Beats Estimates, Stock RisesEarnings Beat Streak - newsline.com
Molina Healthcare (MOH): Examining Its Position in the Healthcare SectorEarnings Expansion Phase - newsline.com
Summit Midstream Corporation (SMC) Holds Near Resistance as Energy Sector Shows Cautious OptimismGap Up Stocks - newsline.com
NBIS Q1 2026 Earnings: EPS Surprise Beats Estimates by 59% Despite Negative EarningsHealthcare Earnings Report - newsline.com
TRADING UPDATES: Unicorn Mineral; Helix Exploration agree acquisitions - London South East
Anthropic Warns AI Could Develop Without Human Oversight, Calls for Regulatory SafeguardsROE Trend Analysis - newsline.com
Karen Bass and Spencer Pratt May Face Runoff in Los Angeles Mayoral RaceOne-Time Gain Impact - newsline.com
Manhattan Bridge Capital Inc (LOAN) Holds Near Support Amid Modest DeclineGolden Cross - newsline.com
Global Fashion Retailer Shuts All Stores After 33 Years: End of an EraFull Year Guidance - newsline.com
MoonLake Immunotherapeutics Signs Manufacturing Agreement with Vetter Pharma – SEC 8-K Filing Details 8 - Minichart
EQIX Q1 2026 Earnings: EPS Slightly Misses Estimates; Stock Edges LowerDividend Earnings Report - The Legal Advocate
Phillies Add Former Blue Jays Switch-Hitter to Bolster Outfield DepthOperating Margin Analysis - newsline.com
LIEN Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
EverQuote (EVER) Q1 2026 Earnings: EPS Surges Past Estimates with 14% BeatQuarterly Earnings - newsline.com
Helix Acquisition Corp. III (HLXC) Holds Steady at $10.22, Signaling Stability in SPAC TerritoryOBV Breakout - The Legal Advocate
India’s Engineering Goods Exports Rise 8.8% in April Despite Decline in UAE, Saudi Arabia ShipmentsEPS Growth Rate - The Legal Advocate
Helix Acquisition Corp. III (HLXC) Holds Steady Near Trust Value Amid Minimal MovementWeekly Profile - The Legal Advocate
Cuprina Holdings (CUPR) Slides 9%: Key Support Levels Under PressureVolume Nodes - The Legal Advocate
HTCR Q2 2025 Earnings: Stunning EPS Beat Drives Double-Digit Stock SurgeBook Value Growth - newsline.com
AI Adoption Faces Cost Hurdle: Reports Suggest Technology May Be More Expensive Than Human LaborEBITDA Analysis - newsline.com
RESEARCH ALLIANCE CORPORATION III ANNOUNCES PRICING OF $75 MILLION INITIAL PUBLIC OFFERING - Yahoo Finance
BlossomHill Therapeutics Expands Board of Directors with the Appointments of Sheila Gujrathi, M.D., and John Schmid - The Manila Times
Airship AI (AISP) Q3 2025 Earnings Miss by Significant: Key TakeawaysCore Business Growth - thelegaladvocate.com
Helix Acquisition Corp. IIClass A Ordinary Shares (NQ: HLXB - The Chronicle-Journal
STARWOOD (STWD) Q1 2026 Results Miss Estimates — EPS $0.39 vs $0.43ROA Comparison - newsline.com
ADAR1/Schneeberger report 1,000,000 HLXC shares (HLXC) - Stock Titan
Number of shareholders of Helix Acquisition Corp. III – NASDAQ:HLXC - TradingView
1.25M shares disclosed by Nantahala in HLXC (HLXC) Schedule 13G - Stock Titan
Helix Acquisition Corp. III Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Helix Acquisition Corp. III (HLXC) earns $0.84M as SPAC trust hits $173.6M - Stock Titan
Balyasny group reports 1.24M shares in Helix Acquisition Corp. III (HLXC) - Stock Titan
Affinity Asset Advisors (HLXC) reports 1.25M shares, a 7% stake - Stock Titan
SUMA Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Guggenheim (GOF) Stalls at $$11.49 — Consolidation Phase 2026-05-14Trend Following Picks - newsline.com
[SCHEDULE 13G] Helix Acquisition Corp. III Passive Investment Disclosure (>5%) - Stock Titan
Finanzdaten der Helix Acquisition Corp Iii-Aktie (HLXC)
Es liegen keine Finanzdaten für Helix Acquisition Corp Iii (HLXC) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.17%
2.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):